Efficacy and safety of onabotulinumtoxinA for treatment of pediatric upper limb spasticity: Primary results
Sign Up to like & getrecommendations! Published in 2018 at "Toxicon"
DOI: 10.1016/j.toxicon.2018.11.080
Abstract: the authors by Karen Pemberton, PhD, of Evidence Scientifi c Solutions, Inc, and funded by Allergan plc. All authors met the ICMJE authorship criteria. Neither honoraria nor payments were made for authorship. Financial arrangements of… read more here.
Keywords: efficacy safety; allergan plc; treatment pediatric; neurotoxin association ... See more keywords